Author

TAYLOR CARLSON

OpenAlex ID: A5016777580

823-P: GLY-200, a Pharmacologic Duodenal Exclusion Therapy, Improved Metabolic Parameters in the DIO Rat

2023 · ASHISH NIMGAONKAR, CHRISTINE BRYANT, et al. · Diabetes · 1

833-P: Duodenal Targeting by Oral Pharmacologic Duodenal Exclusion Therapy for Treatment of Type 2 Diabetes (T2D)

2023 · ASHISH NIMGAONKAR, CHRISTINE BRYANT, et al. · Diabetes

832-P: Coadministration of Metformin with GLY-200, a Clinical-Stage Nonabsorbed Drug for the Treatment of Type 2 Diabetes (T2D), Has No Significant Impact on the Oral Absorption of Metformin in the Rat

2023 · MARK FINEMAN, CHRISTINE BRYANT, et al. · Diabetes

818-P: Chronic Oral Polymeric Duodenal Exclusion Therapy Has Profound Metabolic Benefits in a T2D Rat Model and Affects Duodenal Morphological Enteroplasticity Similar to RYGB surgery: Implications for T2D Therapy

2022 · ASHISH NIMGAONKAR, FLORENCE GUERINA, et al. · Diabetes

Works count: 4

Citation count: 1

H-index: 1

I10-index: